Clinical Trial Update: Effect of Dapagliflozin in Patients With Acute Heart Failure (DAPA-RESPONSE-AHF) [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update investigating dapagliflozin for acute heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Mansoura University | Conditions: Acute Heart Failure | Phase 2, Phase 3 | Status: COMPLETED